Basics

Due to an overwhelming response, this event is sold out.
Please check back in the coming weeks to learn more about our fall CME program on women's issues scheduled for Saturday, September 26, 2009 at the Hyatt Regency Indianapolis.

Indiana Psychiatric Society's 2009 Spring Symposium

Title:
Appropriate Usage of Stimulants and Psychotropics in Unique Pediatric Populations -- Accredited for 6.0 AMA PRA Category 1 Credits™ by the Indiana University School of Medicine

Date:
Saturday, April 25, 2009

Location:
NCAA Conference Center (NCAA Hall of Champions)
700 West Washington St.
Indianapolis, Indiana 46206

• Parking available for $3.00 in the White River State Park Garage accessible from Washington St.
• The NCAA requires a security-issued name tag. Please allow an extra few minutes for this process.
  
• Link to Facility
• Google Map

Program Description:
Psychotropic prescriptions to children have escalated rapidly over the last decade. While the Food and Drug Administration has approved several new pediatric indications in that time period, concern is rising that medications are being prescribed excessively and unwisely. Widespread use of very expensive new medications is also proving burdensome to the Indiana Medicaid system.

This timely conference will focus on safe and empirically validated treatment of major child psychiatric illnesses, including bipolar disorder, depressive disorders, and attention-deficit/hyperactivity disorder. Indiana-specific data on psychotropic use in the Medicaid population will be compared to regional and national data. Appropriate treatment protocols emphasizing reasonable medication options and non-psychotropic treatment alternatives will be reviewed. This symposium will be especially appropriate for primary care providers, general and child/adolescent psychiatrists, nurse practitioners, and behavioral health providers caring for Indiana’s youngest and most vulnerable population.

Brochure

Educational Objectives:
At conclusion of course, participants should be able to:

• Recognize the most common psychiatric problems of children;
• Select evidence based treatments for psychopathology in children;
• Identify potential adverse effects of common treatments for childhood psychopathology;
• Describe the epidemiology and financial costs associated with stimulant, atypical antipsychotics, and anti-depressants use in children enrolled in Indiana Medicaid programs;
• Identify the core elements of Cognitive Behavioral Therapy (CBT) and apply CBT strategies to mood disorders in children;
• Summarize the wrap around service models in the community.

Register:

• Online: Click Here. (Closed.)
• Phone: 1.888.822.9732
• Mail: complete registration form and mail with check payable to:

  Indiana Psychiatric Society
  631 E. New York St.
  Indianapolis IN  46202

Pricing:

• Indiana Psychiatric Society Members -- No charge
• Residents & Students -- No charge
• Physician (non-IPS members) -- $150 before April 11, then $185
• PhD, ANP/RN -- $115 before April 11, then $150
• LCSW, Therapist, & Other Medical Professionals (ie: Pharmacist, Case Worker, etc) -- $75 before April 11, then $115

Note:

Cancellation policy: A refund of 50% of the registration fee will be offered if cancellation is received in writing prior to April 10th.

Event Schedule:
7:45 AM
Registration & continental complimentary breakfast

8:25 – 8:30 AM
Welcome
Kelda Walsh, M.D. – President, IPS
Chief, OCD/Tourette's/Anxiety Disorders Clinic - Riley Hospital for Children

8:30 – 9:30 AM
Behavioral & Emotional Problems of Children: Prevalence & Diagnosis
David W. Dunn, M.D.- Arthur B. Richter Professor of Child Psychiatry –I.U. School of Medicine

9:30– 10:30 AM
Psychotropic Patterns & Trends for Children Enrolled in Indiana Medicaid
Caroline Carney Doebbeling, M.D., M.Sc.- Director, Health Evaluation, Research, Outcomes, and Quality- Indiana Office of Medicaid Policy and Planning

10:30-10:55 AM
Break& complimentary lunch available

10:55-11:00 AM
Comments & introduction of keynote speaker
Senator Patricia Miller - Indiana State Senator, District 32

11:00 AM – 1:15 PM
Keynote Speaker
Optimal Patient Outcomes in Child Psychiatry: A Call for Improving Pediatric Psychopharmacology & Improving Access in a Cost Constrained Environment
Peter S. Jensen, M.D., President & CEO, The REACH Institute

1:15 – 1:45 PM
Panel Discussion

1:45- 2:00 PM
Break

2:00 – 3:00 PM
Mood Disorders: Non-Pharmacologic Interventions for Children
Lynn Bradford, Ph.D., HSPP, Psychologist - Director of Behavioral Health, MDwise, Inc.

3:00 – 3:15 PM
Panel Discussion

3:15 PM
Adjourn

Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Indiana University School of Medicine and the Indiana Psychiatric Society. Indiana University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement:
Indiana University School of Medicine designates this educational activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For Social Workers, Clinical Social Workers, Marriage and Family Therapists and Mental Health Counselors:
The Indiana University School of Medicine is accepted as a provider of approved continuing education units (CEU). A certificate of attendance will be provided to all participants. Verification of the acceptance of CME credit by outside agencies is the responsibility of the registrant.

Faculty Disclosure Statement:
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Indiana University School of Medicine (IUSM) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, and planning committee members participating in an IUSM-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Note: While it offers CME credit, this activity is not intended to provide extensive training or certification in the field.